According to the tumor-suppressing activity of miR-106a by targeting E2F3 (a member of the E2F transcription factor family), it was demonstrated that lncRNA H19 may function as a sponge of miR-106a-5p to upregulate E2F3 expression and consequently promote glucose metabolism and growth in melanoma cells. The gene discussed is E2F3; the disease is neoplasm.